Case report: Axillary lymph node metastases from primary ovarian cancer: a report of two cases and literature review

被引：1

作者：

Abdullah, Norlia ^{[1
]}

Rosly, Nadiah ^{[1
,2
]}

Pauzi, Suria Hayati Md ^{[3
]}

Mustapha, Aida Widure ^{[4
]}

Arifuddin, Yulianty ^{[5
,6
]}

机构：

[1] Univ Kebangsaan Malaysia, Med Fac, Dept Surg, Kuala Lumpur, Malaysia

[2] Ipoh Gen Hosp, Dept Surg, Ipoh, Perak, Malaysia

[3] Univ Kebangsaan Malaysia, Med Fac, Dept Pathol, Kuala Lumpur, Malaysia

[4] Univ Kebangsaan Malaysia, Med Fac, Dept Radiol, Kuala Lumpur, Malaysia

[5] Univ Kebangsaan Malaysia, Med Fac, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia

[6] An Nur Specialist Hosp, Dept Obstet & Gynaecol, Bangi, Selangor, Malaysia

来源：

FRONTIERS IN ONCOLOGY | 2024年 / 14卷

关键词：

metastasis; axillary; lymph node; ovarian; carcinoma; CARCINOMA; FREQUENCY;

D O I：

10.3389/fonc.2024.1384306

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ovarian cancer is usually confined intraperitoneally. Distant metastases at presentation is unusual. Its spread via lymphatics is uncommon, and metastasis to axillary lymph nodes is very rare. We report two cases with presentation of axillary lymphadenopathy without breast involvement. Computed tomography scan identified the ovarian masses. Both had elevated Serum Ca 125. The first case had a Grade 2 ovarian endometrioid carcinoma. The second case had a high-grade serous ovarian carcinoma. These cases illustrate the rarity of axillary lymphadenopathy from ovarian cancer. It is important to identify the primary ovarian carcinoma in order to offer appropriate management. Despite surgery and chemotherapy, both succumbed within 3 years from diagnosis.

引用

页数：6

共 25 条

[1] Influence of cultural practices on breast cancer risks, stage at presentation and outcome in a multi-ethnic developing country [J].

Abdullah, Norlia ;

Mohamed, Norazlina .

ONCOLOGY LETTERS, 2021, 22 (05)

[2] WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma [J].

Al-Hussaini, M ;

Stockman, A ;

Foster, H ;

McCluggage, WG .

HISTOPATHOLOGY, 2004, 44 (02) :109-115

[3]

Azizah A., 2019, Malaysia National cancer registry report (MNCR)

[4]

Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]

[5] Distant metastases in ovarian carcinoma [J].

Cormio, G ;

Rossi, C ;

Cazzolla, A ;

Resta, L ;

Loverro, G ;

Greco, P ;

Selvaggi, L .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (02) :125-129

[6]

Ferlay J EM., 2024, Global Cancer Observatory: Cancer Today (version 1.1)

[7] Frequency of symptoms of ovarian cancer in women presenting to primary care clinics [J].

Goff, BA ;

Mandel, LS ;

Melancon, CH ;

Muntz, HG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (22) :2705-2712

[8] Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study [J].

Huang, Junjie ;

Chan, Wing Chung ;

Ngai, Chun Ho ;

Lok, Veeleah ;

Zhang, Lin ;

Lucero-Prisno, Don Eliseo, III ;

Xu, Wanghong ;

Zheng, Zhi-Jie ;

Elcarte, Edmar ;

Withers, Mellissa ;

Wong, Martin C. S. .

CANCERS, 2022, 14 (09)

[9] FDG PET/CT in staging of advanced epithelial ovarian cancer: Frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread [J].

Hynninen, Johanna ;

Auranen, Annika ;

Carpen, Olli ;

Dean, Kirsti ;

Seppanen, Marko ;

Kemppainen, Jukka ;

Lavonius, Maija ;

Lisinen, Irina ;

Virtanen, Johanna ;

Grenman, Seija .

GYNECOLOGIC ONCOLOGY, 2012, 126 (01) :64-68

[10]

Keng Soon Lean, 2015, Asian Pac J Cancer Prev, V16, P537

← 1 2 3 →